Congress Sounds Alarm Over Illegal Weight-Loss Drug Imports From China - Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY)

Congress Sounds Alarm Over Illegal Weight-Loss Drug Imports From China - Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY)

In a letter to the U.S. Food and Drug Administration (FDA) Commissioner Marty Makary on Friday, over 80 bipartisan members asked the agency to stop counterfeit and copycat versions of GLP-1 drugs like Novo Nordisk A/S’ (NYSE:NVO) Wegovy (semaglutide) and Eli Lilly and Co.’s (NYSE:LLY) Zepbound from flooding the market. The group led by U.S. Representative Richard Hudson and Herbert Conaway wrote the letter urging immediate action against the ris…